Zentiva Group a.s.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zentiva Group a.s.
Agnafit Bidco, comprised of Advent International and an affiliate of GIC Pte Ltd, will pay a premium for the rare disease specialist in an effort to capture value from Sobi’s planned growth.
Zentiva has announced that it is investing a further €27m in expanding its flagship manufacturing plant in Prague, having already pumped €35m into the site over the past three years.
Mabxience and Zentiva have partnered to launch the Alymsys bevacizumab biosimilar rival to Avastin that recently received a pan-European marketing authorization.
Zentiva’s Zent2U B2B unit says that it will be ready to register for a European generic version of Novartis’ Entresto immediately upon data exclusivity expiry, putting its version in position for a “day one” launch once intellectual property protecting the cardiovascular blockbuster expires.
- Generic Drugs
- OTC, Consumer
- Other Names / Subsidiaries
- Solacium Pharma Creo Pharmaceuticals Ltd.